In today’s recent session, 1.41 million shares of the TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) have been traded, and its beta is -0.09. Most recently the company’s share price was $0.64, and it changed around $0.15 or 31.60% from the last close, which brings the market valuation of the company to $0.31M. TCBP at last check was trading at a discount to its 52-week high of $26.80, offering almost -4087.5% off that amount. The share price’s 52-week low was $0.35, which indicates that the recent value has risen by an impressive 45.31% since then. We note from TC BioPharm (Holdings) plc ADR’s average daily trading volume that its 10-day average is 3.85 million shares, with the 3-month average coming to 2.20 million.
TC BioPharm (Holdings) plc ADR stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended TCBP as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. TC BioPharm (Holdings) plc ADR is expected to report earnings per share of 0 for the current quarter.
TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information
Instantly TCBP has been showing a green trend so far today with a performance of 31.60% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.8201 on recent trading dayincreased the stock’s daily price by 21.96%. The company’s shares are currently down -97.48% year-to-date, but still up 25.81% over the last five days. On the other hand, TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) is 42.90% up in the 30-day period. We can see from the shorts that 38332.0 shares have been sold at a short interest cover period of 0.02 day(s).
TC BioPharm (Holdings) plc ADR (TCBP) estimates and forecasts
TC BioPharm (Holdings) plc ADR share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -91.02 percent over the past six months and at a 100.00% annual growth rate that is well above the industry average of 16.70%. Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 45.82%.
TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.01% of TC BioPharm (Holdings) plc ADR shares, and 7.01% of them are in the hands of institutional investors. The stock currently has a share float of 7.02%.
